Alpelisib is a PI3K inhibitor. It’s used for treating breast cancer that’s hormone receptor-positive and HER2-negative, especially in people with PIK3CA mutations. It’s a pill you take.
It’s made to go after the PI3K signaling pathway. You can get Alpelisib in three doses: 50, 200, and 300 mg. They’re all tablets with a coating.
For adults, the suggested dose is 300 mg. You take it once a day, and it’s best with food so it absorbs well. The medicine comes in blister packs, with 28 tablets in each.
Patients need to follow the directions closely to get the most out of the treatment.
